STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD(GPCR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GPCR STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD

休市中 04-19 16:00:00 EDT

36.36

+0.18

+0.50%

盘后36.36

+0.000.00%

16:01 EDT

最高37.47	最低35.70	成交量38.33万
今开36.12	昨收36.18	日振幅4.89%
总市值16.94亿	流通市值12.06亿	总股本4,660万
成交额1,392万	换手率1.16%	流通股本3,318万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"GPCR","market":"US","secType":"STK","nameCN":"STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD","latestPrice":36.36,"timestamp":1713556800000,"preClose":36.18,"halted":0,"volume":383323,"hourTrading":{"tag":"盘后","latestPrice":36.36,"preClose":36.36,"latestTime":"16:01 EDT","volume":4574,"amount":166310.64,"timestamp":1713556900627},"delay":0,"floatShares":33181400,"shares":46598041,"eps":-2.962265,"marketStatus":"休市中","marketStatusCode":7,"change":0.18,"latestTime":"04-19 16:00:00 EDT","open":36.12,"high":37.47,"low":35.7,"amount":13920464.825905,"amplitude":0.048922,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.962265,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1713772800000},"adr":0,"listingDate":1675400400000,"adjPreClose":36.18,"adrRate":3,"postHourTrading":{"tag":"盘后","latestPrice":36.36,"preClose":36.36,"latestTime":"16:01 EDT","volume":4574,"amount":166310.64,"timestamp":1713556900627},"volumeRatio":0.930587},"requestUrl":"/m/hq/s/GPCR","defaultTab":"news","newsList":[{"id":"2428790561","title":"减肥药开发商 Metsera 获得 2.9 亿美元融资","url":"https://stock-news.laohu8.com/highlight/detail?id=2428790561","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2428790561?lang=zh_cn&edition=full","pubTime":"2024-04-18 19:09","pubTimestamp":1713438543,"startTime":"0","endTime":"0","summary":"Metsera公司由风险投资公司ARCH Venture和投资公司Population Health Partners于2022年成立，目前正在开发基于GLP-1机制和其他生物靶点的治疗肥胖症的注射和口服药物。Meanwell 说，Metsera 的 2.9 亿美元融资是迄今为止从领先的医疗保健投资者银团筹集到的资金总额，包括种子轮和 A 轮融资。Meanwell 拒绝就融资的估值发表评论。Meanwell曾担任The Medicines Company首席执行官近20年，该公司于2019年被瑞士制药商诺华  以97亿美元收购， 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2426403739","title":"硕迪生物盘中异动 快速上涨5.07%报43.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426403739","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426403739?lang=zh_cn&edition=full","pubTime":"2024-04-09 02:52","pubTimestamp":1712602332,"startTime":"0","endTime":"0","summary":"北京时间2024年04月09日02时52分，硕迪生物股票出现波动，股价快速拉升5.07%。截至发稿，该股报43.56美元/股，成交量20.4899万股，换手率0.44%，振幅5.20%。机构评级方面，在所有6家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体涨幅为0.15%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409025213861e3fac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409025213861e3fac&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425592202","title":"硕迪生物盘中异动 下午盘股价大涨5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2425592202","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425592202?lang=zh_cn&edition=full","pubTime":"2024-04-06 02:12","pubTimestamp":1712340737,"startTime":"0","endTime":"0","summary":"北京时间2024年04月06日02时12分，硕迪生物股票出现异动，股价快速上涨5.34%。截至发稿，该股报41.40美元/股，成交量20.5107万股，换手率0.44%，振幅5.13%。机构评级方面，在所有6家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体涨幅为1.19%。硕迪生物公司简介：Structure Therapeutics Inc 是一家临床阶段的全球生物制药公司，旨在开发和提供新型口服疗法，以治疗医疗需求未得到满足的各种慢性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040602121787e7e322&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040602121787e7e322&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418366103","title":"硕迪生物盘中异动 急速跳水5.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2418366103","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2418366103?lang=zh_cn&edition=full","pubTime":"2024-03-11 22:40","pubTimestamp":1710168032,"startTime":"0","endTime":"0","summary":"北京时间2024年03月11日22时40分，硕迪生物股票出现波动，股价快速下跌5.40%。截至发稿，该股报34.87美元/股，成交量27.7701万股，换手率0.60%，振幅6.73%。机构评级方面，在所有6家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体跌幅为0.43%。硕迪生物公司简介：Structure Therapeutics Inc 是一家临床阶段的全球生物制药公司，旨在开发和提供新型口服疗法，以治疗医疗需求未得到满足的各种慢性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031122403279195cac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031122403279195cac&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417105090","title":"硕迪生物盘中异动 快速拉升5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2417105090","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417105090?lang=zh_cn&edition=full","pubTime":"2024-03-08 22:40","pubTimestamp":1709908845,"startTime":"0","endTime":"0","summary":"北京时间2024年03月08日22时40分，硕迪生物股票出现异动，股价快速拉升5.21%。截至发稿，该股报37.89美元/股，成交量5.244万股，换手率0.11%，振幅2.25%。机构评级方面，在所有6家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体跌幅为0.52%。硕迪生物公司简介：Structure Therapeutics Inc 是一家临床阶段的全球生物制药公司，旨在开发和提供新型口服疗法，以治疗医疗需求未得到满足的各种慢性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403082240457918a65d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403082240457918a65d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417546640","title":"BUZZ-肥胖症药物开发商 Structure 称现金流将持续到 2026 年，股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2417546640","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2417546640?lang=zh_cn&edition=full","pubTime":"2024-03-08 22:04","pubTimestamp":1709906679,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    3月8日 - ** Structure Therapeutics   股价盘前上涨3.6%至37.30美元** 该公司称 (link)，其年末现金余额为4.673亿美元，预计将为2026年之前的运营和关键临床里程碑提供资金。** 称其中期肥胖症药物试验数据有望在2024年第二季度公布** 截至上次收盘，股价在过去12个月中上涨了46.7","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2417627767","title":"硕迪生物盘中异动 股价大跌5.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2417627767","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417627767?lang=zh_cn&edition=full","pubTime":"2024-03-07 22:31","pubTimestamp":1709821868,"startTime":"0","endTime":"0","summary":"北京时间2024年03月07日22时31分，硕迪生物股票出现异动，股价急速跳水5.78%。截至发稿，该股报37.63美元/股，成交量2.6924万股，换手率0.06%，振幅1.85%。机构评级方面，在所有6家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体涨幅为2.11%。硕迪生物公司简介：Structure Therapeutics Inc 是一家临床阶段的全球生物制药公司，旨在开发和提供新型口服疗法，以治疗医疗需求未得到满足的各种慢性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240307223108861dc458&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240307223108861dc458&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416457337","title":"硕迪生物盘中异动 临近午盘急速跳水5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2416457337","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416457337?lang=zh_cn&edition=full","pubTime":"2024-03-01 00:37","pubTimestamp":1709224655,"startTime":"0","endTime":"0","summary":"北京时间2024年03月01日00时37分，硕迪生物股票出现异动，股价急速下跌5.11%。截至发稿，该股报41.06美元/股，成交量12.0555万股，换手率0.26%，振幅6.75%。机构评级方面，在所有6家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体跌幅为1.81%。硕迪生物公司简介：Structure Therapeutics Inc 是一家临床阶段的全球生物制药公司，旨在开发和提供新型口服疗法，以治疗医疗需求未得到满足的各种慢性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030100373687e74eff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030100373687e74eff&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2414388825","title":"BUZZ-Viking Therapeutics 公司的减肥药在中期试验中获得成功，安进公司股价下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2414388825","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2414388825?lang=zh_cn&edition=full","pubTime":"2024-02-28 01:19","pubTimestamp":1709054390,"startTime":"0","endTime":"0","summary":"    2月27日 - ** 正在开发减肥药的制药商安进  股价下跌2.6%，至278.9美元，拖累蓝筹股道琼斯指数<.DJI ** 规模较小的肥胖症药物开发商Viking Therapeutics的  实验性药物VK2735在一项中期研究中帮助患者实现了 \"显著 \"的体重减轻。** 安进公司将于今年晚些时候公布其主要注射减肥候选药物 , MariTide 的中期试验结果。** Truist Securities 公司分析师 Joon Lee 说，Viking 公司的数据可能会 \"对安进公司在肥胖症方面的期望造成压力\"。** 在美国上市的诺和诺德  股价下跌1.4%，报121.8美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2414039408","title":"硕迪生物盘中异动 早盘大幅上涨6.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2414039408","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2414039408?lang=zh_cn&edition=full","pubTime":"2024-02-27 22:33","pubTimestamp":1709044387,"startTime":"0","endTime":"0","summary":"北京时间2024年02月27日22时33分，硕迪生物股票出现异动，股价快速拉升6.04%。截至发稿，该股报43.51美元/股，成交量2.575万股，换手率0.06%，振幅3.61%。机构评级方面，在所有5家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体跌幅为0.24%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402272233077a4752f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402272233077a4752f9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2413479038","title":"硕迪生物盘中异动 急速下跌5.46%报41.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2413479038","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2413479038?lang=zh_cn&edition=full","pubTime":"2024-02-22 01:39","pubTimestamp":1708537155,"startTime":"0","endTime":"0","summary":"北京时间2024年02月22日01时39分，硕迪生物股票出现异动，股价大幅跳水5.46%。截至发稿，该股报41.00美元/股，成交量9.0426万股，换手率0.19%，振幅5.36%。机构评级方面，在所有5家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体跌幅为0.37%。硕迪生物公司简介：Structure Therapeutics Inc 是一家临床阶段的全球生物制药公司，旨在开发和提供新型口服疗法，以治疗医疗需求未得到满足的各种慢性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022201391587e71ee1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022201391587e71ee1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2410006074","title":"硕迪生物盘中异动 临近收盘股价大涨5.11%报49.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2410006074","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2410006074?lang=zh_cn&edition=full","pubTime":"2024-02-10 04:39","pubTimestamp":1707511174,"startTime":"0","endTime":"0","summary":"北京时间2024年02月10日04时39分，硕迪生物股票出现波动，股价快速上涨5.11%。截至发稿，该股报49.40美元/股，成交量40.778万股，换手率0.88%，振幅4.68%。机构评级方面，在所有5家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体涨幅为0.96%。硕迪生物公司简介：Structure Therapeutics Inc 是一家临床阶段的全球生物制药公司，旨在开发和提供新型口服疗法，以治疗医疗需求未得到满足的各种慢性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402100439347910a1b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402100439347910a1b0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2409847350","title":"焦点-安进公司另辟蹊径，获得减肥意外之财","url":"https://stock-news.laohu8.com/highlight/detail?id=2409847350","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2409847350?lang=zh_cn&edition=full","pubTime":"2024-02-06 19:00","pubTimestamp":1707217209,"startTime":"0","endTime":"0","summary":"安进公司  最先进的候选实验药物激活了GLP-1，同时阻断了GIP。安进公司全球临床开发负责人Narimon Honarpour说，与其他策略相比，将GIP受体阻断与GLP-1刺激相结合对减轻体重的影响最大。安进公司还在研发其他实验性减肥药物，包括一种正在进行一期测试的口服药物。她说，安进公司不会在 2026 年前推出减肥药。Honarpour说，安进公司尚未发现这种关联，但目前的研究正在跟踪这种关联。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2408668976","title":"硕迪生物盘中异动 股价大涨5.18%报45.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2408668976","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2408668976?lang=zh_cn&edition=full","pubTime":"2024-02-02 02:52","pubTimestamp":1706813570,"startTime":"0","endTime":"0","summary":"北京时间2024年02月02日02时52分，硕迪生物股票出现异动，股价大幅上涨5.18%。截至发稿，该股报45.88美元/股，成交量10.672万股，换手率0.23%，振幅5.35%。机构评级方面，在所有5家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体涨幅为0.96%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402020252507a408498&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402020252507a408498&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2407455609","title":"硕迪生物盘中异动 早盘股价大涨5.05%报43.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2407455609","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2407455609?lang=zh_cn&edition=full","pubTime":"2024-01-31 22:35","pubTimestamp":1706711720,"startTime":"0","endTime":"0","summary":"北京时间2024年01月31日22时35分，硕迪生物股票出现异动，股价大幅拉升5.05%。截至发稿，该股报43.30美元/股，成交量9866股，换手率0.02%，振幅4.73%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-23.86百万美元，每股收益-0.62美元，毛利-351022.06美元，市盈率-21.41倍。机构评级方面，在所有5家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体涨幅为0.87%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401312235207a40209f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401312235207a40209f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2404072085","title":"硕迪生物盘中异动 早盘股价大跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2404072085","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2404072085?lang=zh_cn&edition=full","pubTime":"2024-01-19 23:22","pubTimestamp":1705677777,"startTime":"0","endTime":"0","summary":"北京时间2024年01月19日23时22分，硕迪生物股票出现异动，股价急速下跌5.11%。截至发稿，该股报41.44美元/股，成交量8.7241万股，换手率0.19%，振幅5.06%。机构评级方面，在所有5家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体跌幅为0.25%。硕迪生物公司简介：Structure Therapeutics Inc 是一家临床阶段的全球生物制药公司，旨在开发和提供新型口服疗法，以治疗医疗需求未得到满足的各种慢性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240119232257861cbadc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240119232257861cbadc&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.structuretx.com","stockEarnings":[{"period":"1week","weight":-0.0753},{"period":"1month","weight":-0.0588},{"period":"3month","weight":-0.1082},{"period":"6month","weight":-0.4615},{"period":"1year","weight":0.5062},{"period":"ytd","weight":-0.1079}],"compareEarnings":[{"period":"1week","weight":-0.0307},{"period":"1month","weight":-0.0486},{"period":"3month","weight":0.0264},{"period":"6month","weight":0.1756},{"period":"1year","weight":0.2022},{"period":"ytd","weight":0.0418}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"硕迪生物公司于2019年2月在开曼群岛成立，在美国和中国设有运营子公司。该公司是一家临床阶段的全球生物制药公司，旨在开发和提供新型口服疗法，以治疗各种慢性疾病，满足医疗需求。公司的差异化技术平台利用基于结构的药物发现和计算化学专业知识，使公司能够开发口服小分子疗法，用于治疗各种疾病，包括影响代谢、心血管和肺系统的疾病。","exchange":"NASDAQ","name":"STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD","nameEN":"STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD(GPCR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD(GPCR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD,GPCR,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股票,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股票老虎,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股票老虎国际,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD行情,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股票行情,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股价,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股市,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股票价格,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股票交易,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股票购买,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD(GPCR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD(GPCR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}